Surgery Partners, Inc. (NASDAQ:SGRY) Insider Sells $76,028.04 in Stock

Surgery Partners, Inc. (NASDAQ:SGRYGet Free Report) insider Marissa Brittenham sold 3,156 shares of the company’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $24.09, for a total value of $76,028.04. Following the sale, the insider now owns 63,408 shares in the company, valued at approximately $1,527,498.72. This represents a 4.74 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Surgery Partners Stock Down 0.0 %

SGRY stock opened at $23.60 on Friday. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The firm has a market capitalization of $3.01 billion, a PE ratio of -49.17, a PEG ratio of 19.21 and a beta of 2.73. Surgery Partners, Inc. has a 1-year low of $19.50 and a 1-year high of $33.97. The business’s 50 day simple moving average is $23.58 and its 200 day simple moving average is $26.08.

Surgery Partners (NASDAQ:SGRYGet Free Report) last posted its earnings results on Monday, March 3rd. The company reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.01. The business had revenue of $864.40 million for the quarter, compared to analyst estimates of $828.09 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. As a group, research analysts anticipate that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. KBC Group NV grew its holdings in Surgery Partners by 31.8% in the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock valued at $77,000 after buying an additional 576 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. grew its holdings in Surgery Partners by 747.6% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock valued at $124,000 after buying an additional 3,379 shares in the last quarter. State of Wyoming grew its holdings in Surgery Partners by 94.4% in the 4th quarter. State of Wyoming now owns 4,002 shares of the company’s stock valued at $85,000 after buying an additional 1,943 shares in the last quarter. Versor Investments LP acquired a new position in Surgery Partners in the 3rd quarter valued at $271,000. Finally, MeadowBrook Investment Advisors LLC grew its holdings in Surgery Partners by 16.6% in the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company’s stock valued at $218,000 after buying an additional 1,460 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on SGRY. Macquarie dropped their price objective on Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a research note on Tuesday. JPMorgan Chase & Co. dropped their price objective on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research note on Tuesday, December 3rd. Royal Bank of Canada dropped their price objective on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 20th. Finally, Bank of America began coverage on Surgery Partners in a research note on Monday, December 16th. They set a “buy” rating and a $30.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $36.63.

Get Our Latest Stock Report on SGRY

Surgery Partners Company Profile

(Get Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Featured Articles

Insider Buying and Selling by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.